A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Poland- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Poland15 clinical trials in Zory, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on relapsing forms of multiple sclerosis, investigating novel therapeutic approaches and comparing treatment efficacies.
Research aims to evaluate new medications against established treatments for better patient outcomes.
Studies examining advanced treatment options for neurological conditions, with a particular focus on managing relapsing-remitting disease patterns.
Comprehensive research utilizing MRI imaging to track treatment effectiveness.
Innovative research in prostate cancer treatment, specifically focusing on metastatic castration-sensitive cases.
Evaluating new therapeutic combinations to improve patient survival rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.